FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia
Subcutaneous injection cuts the amount of the protein antithrombin, leading to an increase in thrombinContinue Reading
Subcutaneous injection cuts the amount of the protein antithrombin, leading to an increase in thrombinContinue Reading
TUESDAY, April 2, 2025 (HealthDay News) — The shingles vaccine can do more than protect seniors from painful, blistering rashes. It also appears to protect older folks from dementia, researchers say. Seniors who got the shingles vaccine when it became available in the U.K. were 20% less likely to developContinue Reading
WEDNESDAY, April 2, 2025 (HealthDay News) — Lower levels of “bad” LDL cholesterol could mean a lower risk of dementia and Alzheimer’s disease, a new study says. People with low-density lipoprotein (LDL) cholesterol levels lower than 70 mg/dl had a 26% lower risk of dementia and 28% lower risk ofContinue Reading
TUESDAY, April 1, 2025 (HealthDay News) — Hundreds of U.S. research projects aimed at boosting vaccine confidence have been shut down — just as preventable diseases like measles and flu are on the rise. Since Jan. 20, the U.S. Department of Health and Human Services (HHS) has canceled more thanContinue Reading
MONDAY, March 31, 2025 (HealthDay News) — COVID-19 and influenza burned through the U.S. during this year’s cold and flu season, and deadly measles outbreaks have sickened people in 19 states. So what does it take to get people vaccinated against these preventable diseases? Essentially, an outbreak within a person’sContinue Reading
Patients treated with cabozantinib survived significantly longer with no worsening of their disease compared with patients who received placeboContinue Reading
MONDAY, March 31, 2025 (HealthDay News) — A top vaccine official at the U.S. Food and Drug Administration (FDA) is stepping down, warning that vaccine misinformation is coloring the country’s top health decisions. Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said he will resignContinue Reading
Medication approved for uUTIs in women and pediatric patients aged 12 years and olderContinue Reading
TUESDAY, March 25, 2025 (HealthDay News) — Statins are very cheap and highly effective cholesterol-lowering drugs — but high-risk heart patients may have an even better option, a new evidence review says. Combining statins with another drug, ezetimibe, significantly reduces the risk of death in patients with clogged arteries, accordingContinue Reading
Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn diseaseContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.